September 13, 2013
Wal-Mart Stores Inc. was hit with a putative class action in New Jersey federal court Thursday alleging it misled consumers into paying twice as much for its store-brand Equate migraine medicine by deceptively marketing it as being more effective than its regular Equate headache medicine.